Aspire Biopharma
ASBP7.2453.95% ( +0.275 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Aspire Biopharma(ASBP) the Revenue is 28.35 K (--%);the EBIT is -1.633 M (-14.56%);the EPS is -20.57 (+95.93%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
----
----
EBIT
-0.00B14.56%
----
----
EPS
-20.569295.93%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf